Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette- Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676)

  • Details

ClinicalTrials.gov ID: NCT03711032
Diagnosis Type: High Risk
USOR Number: 17213

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - Plano

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  • Details

ClinicalTrials.gov ID: NCT03465722
Diagnosis Type: NA
USOR Number: 18016

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Plano

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

A randomized phase III trial comparing axillary lymph node dissection to axillary radiation in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy (A011202)

  • Details

ClinicalTrials.gov ID: NCT01901094
Diagnosis Type: NA
USOR Number: 16076

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

(I3Y-MC-JPCF) monarchE: A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

  • Details

ClinicalTrials.gov ID: NCT03155997
Diagnosis Type: NA
USOR Number: 17082

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations(FIGHT-201)(INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Melanoma

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Renal Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer (NRG-BR003)

  • Details

ClinicalTrials.gov ID: NCT02488967
Diagnosis Type: NA
USOR Number: 15146

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations(FIGHT-201)(INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Pages